Transformed SCLC (tSCLC) is characterized by high mitotic activity, expression of neuroendocrine markers, and a high prevalence of TP53 and/or RB1 mutations; however, dual TP53/RB1 loss appears necessary but not sufficient for HT [27,28]. Here, TP53 is linked to small cell lung carcinoma.